Hyperion Capital Advisors’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,042	Closed	-$220K	–	61
2022 Q1	$220K	Hold	4,042	–	–	0.08%	53
2021 Q4	$236K	Buy	+4,042	New	+$236K	0.05%	47